Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Skin color may change how alopecia areata looks under a dermoscope.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

FFA in young women is often missed, and no single treatment works best.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

No treatment showed clear superiority for lichen planopilaris.